Gr. Sarantis S.A. (SAR):企業の財務・戦略的SWOT分析

◆英語タイトル:Gr. Sarantis S.A. (SAR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2588
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ギリシャ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gr. Sarantis S.A. (SAR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gr. Sarantis S.A. (Sarantis) is a consumer products company. The company manufactures and distributes a range of products in personal care, household, health and care, and luxury cosmetics. Its cosmetics products include female fragrances and cosmetics, male cosmetics, sun care, hair care, and other personal care products. The household products include food packaging products, insecticides, cleaning tools, and shoe care. The company also offers health and care products including vitamins, testing kits, food supplements and cosmetics; and selective products such as specialized beauty and care products. The company has its operations across Poland, Romania, Bulgaria, Serbia, the Czech Republic, Hungary, Macedonia, Bosnia and Portugal. Sarantis is headquartered in Athens, Greece.

Gr. Sarantis S.A. Key Recent Developments

Mar 21,2017: Sarantis annual net profit increases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Gr. Sarantis S.A. – Key Facts 6
Gr. Sarantis S.A. – Key Employees 7
Gr. Sarantis S.A. – Key Employee Biographies 8
Gr. Sarantis S.A. – Major Products and Services 9
Gr. Sarantis S.A. – History 11
Gr. Sarantis S.A. – Company Statement 14
Gr. Sarantis S.A. – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 16
Section 2 – Company Analysis 17
Company Overview 17
Gr. Sarantis S.A. – Business Description 18
Business Segment: Household Products 18
Overview 18
Performance 18
Business Segment: Mass Market Cosmetics 18
Overview 18
Performance 18
Business Segment: Other Sales 18
Overview 18
Performance 18
Business Segment: Private Label 19
Overview 19
Performance 19
Geographical Segment: Foreign countries 19
Target Markets 19
Performance 19
Geographical Segment: Greece 19
Target Markets 19
Performance 19
Gr. Sarantis S.A. – Corporate Strategy 20
Gr. Sarantis S.A. – SWOT Analysis 21
SWOT Analysis – Overview 21
Gr. Sarantis S.A. – Strengths 21
Gr. Sarantis S.A. – Weaknesses 22
Gr. Sarantis S.A. – Opportunities 23
Gr. Sarantis S.A. – Threats 24
Gr. Sarantis S.A. – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
Section 4 – Company’s Recent Developments 33
Mar 21, 2017: Sarantis annual net profit increases 33
Section 5 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Gr. Sarantis S.A., Key Facts 6
Gr. Sarantis S.A., Key Employees 7
Gr. Sarantis S.A., Key Employee Biographies 8
Gr. Sarantis S.A., Major Products and Services 9
Gr. Sarantis S.A., History 11
Gr. Sarantis S.A., Subsidiaries 15
Gr. Sarantis S.A., Joint Venture 16
Gr. Sarantis S.A., Key Competitors 25
Gr. Sarantis S.A., Ratios based on current share price 26
Gr. Sarantis S.A., Annual Ratios 27
Gr. Sarantis S.A., Annual Ratios (Cont...1) 28
Gr. Sarantis S.A., Annual Ratios (Cont...2) 29
Gr. Sarantis S.A., Interim Ratios 31
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Gr. Sarantis S.A., Performance Chart (2013 - 2017) 30
Gr. Sarantis S.A., Ratio Charts 32

★海外企業調査レポート[Gr. Sarantis S.A. (SAR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Capitec Bank Holdings Limited (CPI):企業の財務・戦略的SWOT分析
    Capitec Bank Holdings Limited (CPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Devon Energy Corp (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its op …
  • Aspyrian Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aspyrian Therapeutics Inc (Aspyrian Therapeutics) is a clinical stage biotechnology company that develops first-in-class precision targeted cancer drugs for the treatment of solid tumors. The company harnesses the Photoimmunotherapy (PIT) platform to develop its products. Its lead pipeline p …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Credito Emiliano SpA:企業の戦略・SWOT・財務分析
    Credito Emiliano SpA - Strategy, SWOT and Corporate Finance Report Summary Credito Emiliano SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Carnarvon Petroleum Ltd (CVN):石油・ガス:M&Aディール及び事業提携情報
    Summary Carnarvon Petroleum Ltd (Carnarvon Petroleum) is an oil and gas company that acquires, explores, and develops oil and gas properties. The company's projects comprise Cerberus and the Phoenix project. It has assets in Barrow sub-basin, Perth basin, and Roebuck basin. Carnarvon Petroleum's Pho …
  • Miromatrix Medical Inc:企業の製品パイプライン分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a biotechnology company engaged in the development extracellular matrix based medical devices in soft tissue reinforcement and advanced wound care. The company offers MIRODERM a porcine liver-derived noncrosslinked acellular biologic wound matri …
  • The Sage Group plc (SGE):企業の財務・戦略的SWOT分析
    The Sage Group plc (SGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Solaris Oilfield Infrastructure Inc (SOI):石油・ガス:M&Aディール及び事業提携情報
    Summary Solaris Oilfield Infrastructure Inc (Solaris) is a provider of supply chain management and logistics solutions for oil and natural gas industry. The company manufactures and provides mobile proppant management systems that unload, store and deliver proppant at oil and natural gas well sites …
  • Immunicom Inc:医療機器:M&Aディール及び事業提携情報
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company that develops non-pharmaceutical therapies for oncology and autoimmune diseases. The company offers immune inhibitors that play a key role in protecting tumors from the body’s natural immune mechanisms. It proprietary Immunophere …
  • Eisai Co., Ltd.:企業の戦略・SWOT・財務分析
    Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Puracap Pharmaceutical LLC (PuraCap) is a drug development company that offers prescription generics and OTC products. The company provides over the counter soft gels and oral solid dosage healthcare products for upper respiratory, pain relief, cough and cold, sleep aid, gastrointestinal, an …
  • Takara Bio Inc (4974):医療機器:M&Aディール及び事業提携情報
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • MGB Biopharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MGB Biopharma Ltd (MGB Biopharma) is a a biopharmaceutical company which develops novel class of anti-infectives using Minor Groove Binder (MGBs) compounds. Its lead drug candidate MGB-BP-3 in the field of antibacterial resistance is active against may Gram-positive bacteria. MGB Biopharma a …
  • Printpack Inc:企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Brooks MacDonald Group PLC (BRK)
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Eversource Energy:企業の発電所・SWOT分析2018
    Eversource Energy - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • FactSet Research Systems Inc. (FDS):企業の財務・戦略的SWOT分析
    FactSet Research Systems Inc. (FDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Institut Curie-製薬・医療分野:企業M&A・提携分析
    Summary Institut Curie is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biolog …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

◆H&Iグローバルリサーチ株式会社のお客様(例)◆